Skip to main content
HUMASIS CO., LTD. logo

HUMASIS CO., LTD. — Investor Relations & Filings

Ticker · 205470 ISIN · KR7205470008 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2022-12-29 Regulatory Filings
Country KR South Korea
Listing KO 205470

About HUMASIS CO., LTD.

https://www.humasis.com/en/

Humasis Co., Ltd. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) devices, with a primary focus on Point-of-Care Testing (POCT). The company develops and produces a range of rapid diagnostic solutions, including immunodiagnostic kits for the early screening of various diseases, compact instruments for quantitative analysis, and personal health care products. A key operational strength is the in-house development and production of critical bio-materials, such as diagnostic immune antigens, which ensures the consistent performance and accuracy of its products. Humasis aims to provide technologies for precise and rapid disease analysis to support clinical decision-making and promote individual health management.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약해지
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure from Humasis regarding the termination of a single sales and supply contract with Celltrion. It details the contract value, the reason for termination (unilateral notice from the counterparty), and the legal status. Since this is a specific regulatory disclosure of a material event (contract termination) that does not fit into categories like M&A, dividends, or share transactions, it falls under the general regulatory filing category.
2022-12-29 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition of Treasury Shares via Trust Agreement' (신탁계약등에의한취득상황보고서) filed with the Financial Supervisory Service (금융감독원). It details the status of a company's share buyback program conducted through a trust contract with a brokerage firm. According to the provided definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2022-12-29 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or the meeting minutes themselves, but rather serves as a formal regulatory notice of the procedural steps required for the meeting. Given it is a standard regulatory notification regarding corporate governance procedures, it fits best under the RNS category.
2022-12-16 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for Humasis, detailing the date, location, and agenda items (such as board and auditor appointments). This type of filing is a standard regulatory requirement for notifying shareholders of upcoming meetings and proxy-related matters. In the context of the provided categories, this fits best under Proxy Solicitation & Information Statement (PSI), as it provides the necessary information for shareholders to prepare for the upcoming vote.
2022-12-08 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and the closure of the shareholder register for an upcoming Extraordinary General Meeting (EGM). It does not contain the full proxy materials or the meeting results themselves, but rather serves as a formal regulatory notice of the administrative procedure for the meeting. Given it is a standard regulatory disclosure that does not fit into specific categories like 'PSI' (which would be the full proxy statement) or 'DVA' (which would be the results), it is best classified as a general regulatory filing.
2022-12-08 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Exchange regarding the termination of a trust contract for the acquisition of treasury shares (자기주식취득 신탁계약 해지 결정). This is a direct report of a company's transaction involving its own shares (share buyback/trust termination). According to the provided definitions, 'Transaction in Own Shares' (POS) is the most accurate category for reports concerning share buybacks or the termination of share repurchase trust agreements.
2022-11-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.